Gps Wealth Strategies Group, LLC Gilead Sciences, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $653 Million
- Q2 2024
A detailed history of Gps Wealth Strategies Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 5,777 shares of GILD stock, worth $478,451. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,777
Previous 29,057
80.12%
Holding current value
$478,451
Previous $2.13 Million
81.39%
% of portfolio
0.06%
Previous 0.35%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$9.99 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.55 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.32 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.91 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $104B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...